论文信息 - The e13a2 BCR‐ABL transcript negatively affects sustained deep molecular response and the achievement of treatment‐free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors - 字舞流文

The e13a2 BCR‐ABL transcript negatively affects sustained deep molecular response and the achievement of treatment‐free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors

G. Ruggeri | G. Rossi | A. Tucci | F. Schieppati | C. Bottelli | E. Borlenghi | M. Farina | C. Pagani | E. Cerqui | M. Capucci | M. D'adda | S. Ferrari | D. Gramegna | A. Passi | Adriana Maifredi | M. D’adda